PERCEPTION OF QUALIFIED MEDICAL PRACTITIONERS TOWARDS PRESCRIBING IN INTERNATIONAL NON-PROPRIETARY (GENERIC) NAMES – AN OBSERVATIONAL, CROSS SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN INDIA

  • Manab Nandy Professor, Dept. of Pharmacology, Medical College Kolkata.
  • KUSHAL BANERJEE
  • INDRANIL BISWAS
  • KAJORI NANDY
  • SOUVIK MAJUMDER
  • AYAN MUKHERJEE
  • ALAK KUMAR DAS

Abstract

Objectives: The study was conducted to assess the perception and practice of medical practitioners, working in tertiary care and teaching institutions in Eastern India, regarding the use of generic (non proprietary) names while prescribing.  The study tried to assess their perception towards using drugs from the National List of Essential Medicine (NLEM), as well.


 


Methods: An observational, cross-sectional study was conducted. Medical practitioners attached to the institution were considered for the study and those who gave voluntarily consent were included. 100 participants were interviewed based on convenient random sampling. They were provided with the study questionnaire and the responses were analyzed using Microsoft Excel 2007 using charts and tables.


 


Results:  Majority (43/100) did not feel that generic medicines are as effective as reputed brands, while 32 felt they are of equally effective. 45% (45/99) felt generics to be equally safe as and 24% (24/99) did not feel so. 86% considered generics to be cheaper. 56% did not prefer to substitute with generics in all conditions. About 73% had doubts regarding the quality of production of generics. The decision to use generics was mostly influenced by lower cost (73%) and by administrative pressure (53%). 58% felt that the NLEM does not contain all the medicines they would require in practice. 94% agreed to prescribe  more in generics if the quality may be ensured.


Conclusion: Awareness about the NLEM and about generics needs to be improved. Authorities need to ensure the quality of generics and assure the prescribers about it.

Keywords: Generic name, Perception of Qualified Medical Practitioners, Observational, Cross-sectional Study

References

[1] Tripathi KD. Essentials of medical pharmacology. Eighth edition. New Delhi: Jaypee Brothers Medical Publishers; 2019. 1064 p.
[2] WHO | Guidance on INN [Internet]. WHO. World Health Organization; [cited 2020 Jun 7]. Available from: https://www.who.int/medicines/services/inn/innquidance/en/
[3] MCI_CircularUseofGenericNames20170421.pdf [Internet]. [cited 2020 Jun 7]. Available from: http://www.ipgmer.gov.in/PharmacovigilanceCommittee/MCI_CircularUseofGenericNames20170421.pdf
[4] Roy V, Rana P. Prescribing generics: All in a name. Indian J Med Res. 2018;147(5):442–4.
[5] Kamath A. Prescribing generic drugs using a generic name: Are we teaching it right? Indian J Med Ethics [Internet]. 2016 Jul [cited 2020 Jul 3];(3). Available from: http://ijme.in/articles/prescribing-generic-drugs-using-a-generic-name-are-we-teaching-it-right/?galley=html
[6] Thakre R, Patil P. Generic drugs: a call for balanced approach. Indian Pediatr. 2017 15;54(8):692.
[7] Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95(2–3):229–235.
[8] Dunne SS, Shannon B, Cullen W, Dunne CP. Beliefs, perceptions and behaviours of GPs towards generic medicines. Fam Pract. 2014 Aug;31(4):467–74.
[9] Riner B, Bussy A, Hélène-Pelage J, Moueza N, Lamy S, Carrère P. “No generics, Doctor!” The perspective of general practitioners in two French regions. BMC Health Serv Res. 2017 Nov 9;17(1):707.
[10] Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, et al. Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy. 2004;70(1):23–32.
[11] Lewek P, Smigielski J, Kardas P. Factors affecting the opinions of family physicians regarding generic drugs–a questionnaire based study. Bosn J Basic Med Sci. 2015;15(1):45.
[12] Hassali MA, Kong DC, Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. J Generic Med. 2006;3(3):214–225.
[13] Spiegel W, Mlczoch-Czerny M-T, Jens R, Dowrick C. Quality circles for pharmacotherapy to modify general practitioners’ prescribing behaviour for generic drugs. J Eval Clin Pract. 2012;18(4):828–834.
[14] Fadare JO, Adeoti AO, Desalu OO, Enwere OO, Makusidi AM, Ogunleye O, et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):639–650.
[15] O’Leary A, Usher C, Lynch M, Hall M, Hemeryk L, Spillane S, et al. Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland. BMC Res Notes. 2015 Dec 15;8:790.
[16] ?ati? T, Avdagi? L, Martinovi? I. Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina. Med Glas Off Publ Med Assoc Zenica-Doboj Cant Bosnia Herzeg. 2017 Feb 1;14(1):25–32.
[17] Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, et al. Greek physicians’ perceptions on generic drugs in the era of austerity. Scientifica [Internet]. 2015;2015. Available from: http://dx.doi.org/10.1155/2015/251792
[18] El-Dahiyat F, Kayyali R, Bidgood P. Physicians’ perception of generic and electronic prescribing: A descriptive study from Jordan. J Pharm Policy Pract. 2014;7(1):7.
[19] Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother. 2011;45(1):31–38.
[20] Kristina SA, Salsabila NN. Medical doctors’ attitude toward generic substitution in prescribing practice: A survey from Yogyakarta.
[21] Patel A, Gauld R, Norris P, Rades T. Quality of generic medicines in South Africa: perceptions versus reality–a qualitative study. BMC Health Serv Res. 2012;12(1):297.
[22] Gupta SK, Nayak RP, Vidyarthi SK. A study on the knowledge, attitude, and practice of generic medicines among the doctors in a tertiary care teaching hospital in South India. Natl J Physiol Pharm Pharmacol. 2015;5(1):39.
[23] Tandel K, Patel N, Zaiwala S, Chavda N, Dhanani J. A study of knowledge, attitude, and practice on generic drugs among teaching faculties at a tertiary care teaching hospital in South Gujarat, India. Natl J Physiol Pharm Pharmacol. 2018;1.
[24] Gupta R, Malhotra A, Malhotra P. A study on assessment of awareness on generic drugs among doctors in a tertiary care teaching hospital in north India. Int J Res Med Sci. 2018 Mar 28;6(4):1362–7.
[25] Zaverbhai KD, Dilipkumar KJ, Kalpan DC, Kiran DM. Knowledge, attitude and practice of resident doctors for use of generic medicines at a tertiary care hospital. J Young Pharm. 2017 Apr 5;9(2):263–6.
[26] Patel HJ, Paras R. Perceived quality of medical practitioners towards generic medicine: An exploratory investigation. J Manage Res Aanal. 2016;3(3):101–9.
[27] Kshirsagar MJ, Langade D, Patil S, Patki PS. Prescribing patterns among medical practitioners in Pune, India. Bull World Health Organ. 1998;76(3):271–5.
[28] Patil JR, Jaykare SC, Motghare VM, Padwal SL, Deshmukh VS. Awareness about generic drug prescription amongst practitioners: A knowledge attitude practice survey at rural set up. Int J Basic Clin Pharmacol. 2016;5(3):707–12.
[29] Gorantla NC, Penupothu SN. A comparative analysis of generic prescribing patterns among teaching and non-teaching clinicians in Nellore, India. Int J Basic Clin Pharmacol. 2018 Mar 23;7(4):622–5.
[30] Tripathi S, Bhattacharya S. Patient perception about generic vs. branded medicines prescribed in a tertiary care hospital in Northern India -a descriptive study. Indian J Pharm Pract. 2018 Jun 15;11(2):91–5.
[31] Lagarce L, Lusson-Brisset C, Bruhat C, Diquet B, Lainé-Cessac P. How practitioners view generic drugs: an opinion study from general practitioners in Maine-et-Loire (France). Therapie. 2005 Feb;60(1):67–74.
[32] Gossell-Williams M. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Med J. 2007;56(5):458.
[33] Toverud E-L, Hartmann K, H\aakonsen H. A systematic review of physicians’ and pharmacists’ perspectives on generic drug use: what are the global challenges? Appl Health Econ Health Policy. 2015;13(1):35–45.
[34] Dixit A, Kumar N, Kumar S. Use of generic medicines: challenges and benefits. J Health Manag. 2018 Mar;20(1):84–90.
Statistics
1 Views | Downloads
How to Cite
Nandy, M., K. BANERJEE, I. BISWAS, K. NANDY, S. MAJUMDER, A. MUKHERJEE, and A. KUMAR DAS. “PERCEPTION OF QUALIFIED MEDICAL PRACTITIONERS TOWARDS PRESCRIBING IN INTERNATIONAL NON-PROPRIETARY (GENERIC) NAMES – AN OBSERVATIONAL, CROSS SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 14, no. 2, Feb. 2021, https://innovareacademics.in/journals/index.php/ajpcr/article/view/39867.
Section
Original Article(s)